These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29230398)

  • 1. Insulin Signaling Deficiency Produces Immobility in
    Dagenhardt J; Trinh A; Sumner H; Scott J; Aamodt E; Dwyer DS
    Mol Neuropsychiatry; 2017 Nov; 3(2):97-107. PubMed ID: 29230398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
    Noda Y; Yamada K; Furukawa H; Nabeshima T
    Br J Pharmacol; 1995 Nov; 116(5):2531-7. PubMed ID: 8581295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavioral assessment of neuroleptics (3)--Schizophrenia negative symptoms-like model induced by PCP].
    Noda Y; Nabeshima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):123-8. PubMed ID: 8905801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions.
    Noda Y; Kamei H; Mamiya T; Furukawa H; Nabeshima T
    Neuropsychopharmacology; 2000 Oct; 23(4):375-87. PubMed ID: 10989264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
    Noda Y; Nabeshima T
    Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
    Li Y; Raaby KF; Sánchez C; Gulinello M
    Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice.
    Noda Y; Mamiya T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1997 Apr; 324(2-3):135-40. PubMed ID: 9145763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
    Chindo BA; Adzu B; Yahaya TA; Gamaniel KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):310-6. PubMed ID: 22561603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.
    Weiner I; Schiller D; Gaisler-Salomon I; Green A; Joel D
    Behav Pharmacol; 2003 May; 14(3):215-22. PubMed ID: 12799523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
    Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
    Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobility time during the forced swimming test predicts sensitivity to amitriptyline, whereas traveled distance in the circular corridor indicates resistance to treatment in female Wistar rats.
    Flores-Serrano AG; Zaldívar-Rae J; Salgado H; Pineda JC
    Neuroreport; 2015 Mar; 26(5):233-8. PubMed ID: 25646581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor.
    Weeks KR; Dwyer DS; Aamodt EJ
    ACS Chem Neurosci; 2010 Jun; 1(6):463-73. PubMed ID: 22778838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common muscarinic pathway for diapause recovery in the distantly related nematode species Caenorhabditis elegans and Ancylostoma caninum.
    Tissenbaum HA; Hawdon J; Perregaux M; Hotez P; Guarente L; Ruvkun G
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):460-5. PubMed ID: 10618440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD; Sanger TM
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test.
    Langen B; Dost R; Egerland U; Stange H; Hoefgen N
    Psychopharmacology (Berl); 2012 May; 221(2):249-59. PubMed ID: 22147257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.